TFEB and tuberous sclerosis: Whether the clinical manifestations of human TSC are primarily the result of hyperactivity of the canonical substrates or hyperactivity of the non-canonical substrates remains an open question, but it is clear that in the murine kidney, the non-canonical substrate TFEB predominates50.